Effects of Mainstream and Environmental Tobacco Smoke on the Immune System in Animals and Humans: A Review
Authors:
Jerry D. Johnson abc;
David P. Houchens def;
William M. Kluwe ghi;
Douglas K. Craig jkl;
Gerald L. Fisher mno
| Affiliations: | a Idaho State University, Pocatello |
| b Purdue University, West Lafayette, Indiana | |
| c Department of Health and Molecular Sciences, Battelle Columbus Division, Columbus, Ohio | |
| d Stetson University, Deland, Florida | |
| e Washington University, Washington, Columbus, Ohio | |
| f Director of Laboratory and Clinical Sciences, Neoprobe Corporation, Columbus, Ohio | |
| g University of Minnesota, Minneapolis | |
| h Michigan State University, East Lansing | |
| i Exploratory Toxicology, Pfizer Central Research, Groton, Connecticut | |
| j University of Witwatersrand, Johannesburg, South Africa | |
| k University of Rochester, Rochester, New York | |
| l Department of Health and, Molecular Sciences, Battelle Columbus Division, Columbus, Ohio | |
| m Northeastern University, Boston, Massachusetts | |
| n University of California, Boston, Massachusetts | |
| o Sandoz Research Institute, East Hanover, New Jersey |
DOI:
10.3109/10408449009089870
Publication Frequency:
10 issues per year
Subject:
Toxicology;
Formats available:
PDF
(English)
View Article:
View Article (PDF)
Abstract
This review evaluates the available information on the effects of mainstream and environmental tobacco smoke on the immune system in animals and humans. The primary emphasis is on mainstream smoke since little information is available on the effects of environmental smoke. The effects of mainstream tobacco smoke on the immune system in humans and animals are similar. Animals exposed to mainstream tobacco smoke for periods of a few weeks generally exhibit a slight immu-nostimulation. However, subchronic and chronic exposure studies indicate that immunosuppressive changes develop. Lymphocyte proliferation in response to the mitogens PHA and LPS is decreased, suggesting compromise of cell function. Antibody production can be suppressed. Smoke-exposed animals that are challenged with metastasizing tumors or viruses have been shown to exhibit a higher incidence of tumorigenic and infectious diseases, respectively. Localized immunological changes in the lung can include reduction of bronchus-associated lymphoid tissue and immunoglobulin levels. Smoking-related changes in the peripheral immune system of humans have included elevated WBC counts, increased cytotoxic/suppressor and decreased inducer/helper T-cell numbers, slightly suppressed T-lymphocyte activity, significantly decreased natural killer cell activity, lowered circulating immunoglobin titers, except for IgE which is elevated, and increased susceptibility to infection. The effects of environmental tobacco smoke on the immune system, in contrast to mainstream tobacco smoke, have just begun to be investigated and information available in the literature, to date, is limited. Immunoreactive substances are known to be present in environmental tobacco smoke, but to date, environmental tobacco smoke has been more closely associated with irritation than sensitization. A few studies have indicated a potential for environmental smoke-induced hypersensitivity and suppression of immunoregulatory substances. In contrast, other investigators have failed to detect immunological or other biological changes associated with environmental smoke. Clearly, more research is needed to resolve these differences.
|
| view references (219) |


Download Citation
CiteULike
Del.icio.us
BibSonomy
Connotea